ALEC Insider Transactions — Page 3
329 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-23 | Sale | 3,541.0 | $26.05 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-23 | Sale | 3,541.0 | $26.05 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-23 | Sale | 11,057.0 | $26.05 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-23 | Sale | 11,057.0 | $26.05 |
| Paul Robert | Chief Medical Officer | 2020-03-13 | Sale | 176.0 | $24.46 |
| Paul Robert | Chief Medical Officer | 2020-03-13 | Sale | 5,459.0 | $23.49 |
| Paul Robert | Chief Medical Officer | 2020-03-13 | Sale | 2,884.0 | $22.47 |
| Paul Robert | Chief Medical Officer | 2020-03-13 | Sale | 1,481.0 | $21.57 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-02 | Sale | 38,808.0 | $26.0 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-03-02 | Sale | 38,808.0 | $26.0 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-02 | Sale | 38,808.0 | $26.0 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-02 | Sale | 445,086.0 | $26.0 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-03-02 | Sale | 445,086.0 | $26.0 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-02 | Sale | 445,086.0 | $26.0 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-03-02 | Sale | 1,390,309.0 | $26.0 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-03-02 | Sale | 1,390,309.0 | $26.0 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-03-02 | Sale | 1,390,309.0 | $26.0 |
| King Robert | Chief Development Officer | 2020-02-14 | Sale | 10,332.0 | $29.77 |
| King Robert | Chief Development Officer | 2020-02-14 | Sale | 4,668.0 | $29.09 |
| Paul Robert | Chief Medical Officer | 2020-02-14 | Sale | 7,000.0 | $29.74 |
| Paul Robert | Chief Medical Officer | 2020-02-14 | Sale | 3,000.0 | $29.07 |
| Oney Sabah | Chief Business Officer | 2020-02-07 | Sale | 19,900.0 | $35.03 |
| Yu Calvin | Vice President, Finance | 2020-02-07 | Sale | 24,033.0 | $35.02 |
| Yu Calvin | Vice President, Finance | 2020-02-06 | Sale | 2,621.0 | $35.0 |
| Oney Sabah | Chief Business Officer | 2020-02-06 | Sale | 100.0 | $35.0 |
| Paul Robert | Chief Medical Officer | 2020-02-05 | Sale | 10,000.0 | $32.1 |
| Oney Sabah | Chief Business Officer | 2020-02-04 | Sale | 16,667.0 | $30.0 |
| SCHELLER RICHARD H | Director | 2020-02-04 | Sale | 10,000.0 | $29.67 |
| Yu Calvin | Vice President, Finance | 2020-02-04 | Sale | 63,541.0 | $30.04 |
| Wehner David M. | Director | 2020-02-03 | Purchase | 20,000.0 | $25.0 |
| Paul Robert | Chief Medical Officer | 2020-01-30 | Sale | 8,000.0 | $28.0 |
| Oney Sabah | Chief Business Officer | 2020-01-27 | Sale | 14,467.0 | $25.05 |
| Oney Sabah | Chief Business Officer | 2020-01-23 | Sale | 2,200.0 | $25.21 |
| Paul Robert | Chief Medical Officer | 2020-01-23 | Sale | 599.0 | $25.22 |
| Paul Robert | Chief Medical Officer | 2020-01-23 | Sale | 5,401.0 | $24.22 |
| King Robert | Chief Development Officer | 2020-01-22 | Sale | 3.0 | $22.01 |
| King Robert | Chief Development Officer | 2020-01-21 | Sale | 14,997.0 | $22.01 |
| Paul Robert | Chief Medical Officer | 2020-01-15 | Sale | 10,000.0 | $18.67 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-01-09 | Sale | 1,392.0 | $19.5 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-01-09 | Sale | 1,392.0 | $19.5 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-01-09 | Sale | 1,392.0 | $19.5 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-01-09 | Sale | 91,818.0 | $19.5 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-01-09 | Sale | 91,818.0 | $19.5 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-01-09 | Sale | 91,818.0 | $19.5 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2020-01-09 | Sale | 286,787.0 | $19.5 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2020-01-09 | Sale | 286,787.0 | $19.5 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2020-01-09 | Sale | 286,787.0 | $19.5 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-26 | Sale | 1,200.0 | $18.6 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-26 | Sale | 1,200.0 | $18.6 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-26 | Sale | 1,200.0 | $18.6 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-26 | Sale | 2,325.0 | $18.6 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-26 | Sale | 2,325.0 | $18.6 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-26 | Sale | 2,325.0 | $18.6 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-26 | Sale | 7,275.0 | $18.6 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-26 | Sale | 7,275.0 | $18.6 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-26 | Sale | 7,275.0 | $18.6 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-24 | Sale | 8,000.0 | $19.59 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-24 | Sale | 8,000.0 | $19.59 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-24 | Sale | 8,000.0 | $19.59 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-24 | Sale | 15,476.0 | $19.59 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-24 | Sale | 15,476.0 | $19.59 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-24 | Sale | 15,476.0 | $19.59 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-24 | Sale | 48,324.0 | $19.59 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-24 | Sale | 48,324.0 | $19.59 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-24 | Sale | 48,324.0 | $19.59 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-23 | Sale | 10,400.0 | $19.82 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-23 | Sale | 10,400.0 | $19.82 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-23 | Sale | 10,400.0 | $19.82 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-23 | Sale | 20,350.0 | $19.82 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-23 | Sale | 20,350.0 | $19.82 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-23 | Sale | 20,350.0 | $19.82 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-23 | Sale | 63,535.0 | $19.82 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-23 | Sale | 63,535.0 | $19.82 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-23 | Sale | 63,535.0 | $19.82 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-20 | Sale | 37,900.0 | $19.66 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-20 | Sale | 37,900.0 | $19.66 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-20 | Sale | 37,900.0 | $19.66 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-20 | Sale | 73,879.0 | $19.66 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-20 | Sale | 73,879.0 | $19.66 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-20 | Sale | 73,879.0 | $19.66 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-20 | Sale | 230,721.0 | $19.66 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-20 | Sale | 230,721.0 | $19.66 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-20 | Sale | 230,721.0 | $19.66 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-17 | Sale | 105,500.0 | $18.52 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-17 | Sale | 105,500.0 | $18.52 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-17 | Sale | 105,500.0 | $18.52 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-17 | Sale | 205,793.0 | $18.52 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-17 | Sale | 205,793.0 | $18.52 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-17 | Sale | 205,793.0 | $18.52 |
| ORBIMED ADVISORS LLC | TenPercentOwner | 2019-12-17 | Sale | 642,807.0 | $18.52 |
| ORBIMED CAPITAL LLC | TenPercentOwner | 2019-12-17 | Sale | 642,807.0 | $18.52 |
| OrbiMed Capital GP IV LLC | TenPercentOwner | 2019-12-17 | Sale | 642,807.0 | $18.52 |
| Paul Robert | Chief Medical Officer | 2019-12-13 | Sale | 10,000.0 | $20.03 |
| Oney Sabah | Chief Business Officer | 2019-12-12 | Sale | 6,810.0 | $20.13 |
| Oney Sabah | Chief Business Officer | 2019-12-10 | Sale | 500.0 | $20.01 |
| Oney Sabah | Chief Business Officer | 2019-12-09 | Sale | 2,300.0 | $20.07 |
| Oney Sabah | Chief Business Officer | 2019-12-06 | Sale | 5,156.0 | $20.02 |
| Oney Sabah | Chief Business Officer | 2019-12-05 | Sale | 1,500.0 | $20.0 |
| Yu Calvin | Vice President, Finance | 2019-12-03 | Sale | 1,315.0 | $18.31 |
| King Robert | Chief Development Officer | 2019-11-15 | Sale | 7,500.0 | $15.92 |